5 Fotoğraf
Prof. Dr. Murat Kuloğlu
Psikoz, Kişilik Bozuklukları, Travma Sonrası Stres Bozukluğudevamı
Son Değerlendirme
Murat hocam gerçek çok başarılı ve işinde uzman bir insan.Hastalığım boyunca yakından ilgilendi ve...devamı
Adres
Prof.Dr Murat Kuloğlu Özel MuayenehanesiHaritada Gör
Ögretmenevler Mah Atatürk blv Zeki Plaza No :96 Kat :4 Daire :7
Konyaaltı/AntalyaUzmanlık Hizmetleri
Bireysel Terapi
Depresyon tedavisi
Madde bağımlılığı
Psikoterapi
Yaygın anksiyete
Yetişkin psikoterapisi
Kaygı Bozuklukları
Kumar bağımlılığı tedavisi
Psikiyatrik muayene
Aile terapisi
İmkanlar
Wi-fi, Online Doktor Danışma
Ödeme Yöntemleri
- • Kredi kartı ile ödeme
- • Nakit
Klinik Fotoğrafları
Özgeçmiş
Prof. Dr. Murat Kuloğlu, lise öğreniminin ardından Fırat Üniversitesi Tıp Fakültesi'ni 1989 yılında birincilikle tamamlamıştır. Uzmanlık eğitimini ise 1991-95 yılları arasında Atatürk Üniversitesi'nde yapmıştır. Fırat Üniversitesi Tıp Fakültesi Ruh Sağlığı ve Hastalıkları Ana Bilim Dalın'da 2003 yılında doçent, 2009 yılında ise profesör ünvanını almıştır.
Görüşler
Görüşlerinizi Önemsiyoruz
Uzmanlar ile ilgili görüşlerinizi belirtmeden önce moderasyon sürecimiz hakkında daha fazlasını öğrenin.
5.0
★★★★★
Toplam 11 geribildirimZamanlama5.0
İlgi5.0
Ortam5.0
M
Mus*** T***18.08.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0N
Nur*** S***18.08.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0S
Seb*** S***13.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0İ
İla*** ***04.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0İ
İla*** U***04.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Cok ilgili ve isinde uzman bir isim inanılmaz yararını gördük her zaman terchimiz
D
Dam*** K***03.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0E
ESE*** Ş***02.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0S
Sin*** S***02.07.2021
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0B
Ber*** K***05.05.2020
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0B
Ban*** M***06.04.2020
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Mesleki Bilgiler
Deneyim Süresi
Şubat 1991 - Günümüz (34 yıl)
34 yıllık mesleki deneyim
Diploma Aldığı Kurum
Firat Üni̇versi̇tesi̇
Uzmanlık Aldığı Kurum
ATATÜRK ÜNIVERSITESI
Deneyimler
Prof.Dr Murat Kuloğlu Özel Muayenehanesi
Yabancı Diller
İngilizce
Yayınlar
1. “Comparison of sociodemographic, clinical and phenomenological charasteristics of Turkish and French patients suffering from obsessive-compulsive disorder,’’ Can. J. Psychiatry, 45, 848, 2000
2. “Color and number preferences of patients with psychiatric disorders in Eastern Turkey,’’ Percept Mot Skills, 94, 207-13, 2002
3. “Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive compulsive disorder,” Neuropsychobiology, 46, 27-32, 2002
4.“Antioxidant enzyme and malondialdehyde levels in patients with panic disorder,” Neuropyschobiology, 46, 186-9, 2002
5. “Serum leptin and cholesterol values in the suicide attempters,’’ Neuropsychobiology, 45, 124-7, 2002
6. “Serum cholesterol and leptin values in patients with borderline personality disorder” Neuropsychobiology, 45, 167-71, 2002
7. “Weight gain and serum leptin levels in patients on lithium treatment,’’ Neuropsychobiology, 46, 67-9, 2002
8. “Lipid peroxidation and antioxidant enzyme levels of patients with schizophrenia and bipolar disorder,’’ Cell Biochem Funct, 20, 171-5, 2002
9. “Bone metabolism and bone mineral density in premenapausal women with mild depression,’’ Yonsei Med J, 43, 101-8, 2002
10. “Serum leptine levels in patients with premature ejeculation,” Arch Andrology,48, 345-50, 2002
11. “Neopterin levels and dexamethasone supression test in posttraumatic stress disorder,” Eur Arch Psychiatry Clin Neurosci, 252, 161-5, 2002
12. “Sildenafil use in patients with olanzapine-induced erectile dysfunction,” Int. J. Impotance Res, 14, 547-9, 2002 (10 p)
13. “The efficacy of citalopram in the treatment of premature ejaculation: a placebo controlled study,” Int. J. Impotance Res, 14, 502-5, 2002
14. “Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings,” Hum. Psychopharmacol. Clin. Exp, 17, 401-5, 2002
15. “Serum leptin and cholesterol levels in the patients with bipolar disorder,” Neuropyschobiology, 46, 176-9, 2002
16. “Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidolin patients with schizophrenia,” Arch. Med. Res, 33, 562-5, 2002
17. “Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo- controlled study,’’ Int. Clin. Psychopharmacol, 17, 115-9, 2002
18. “The detergent is circulating in my blood: A case report,” Int. J. Psychiatr. Clin. Pract, 6, 117-9, 2002
19. “Quetiapine-associated and dose related hypomania in a woman with schizophrenia,’’ European Psychiatry, 17, 1-2, 2002
20. “Serum iron levels in schizophrenic patients with or without akathisia,” Eur. Neuropsychopharmacol, 13, 67-71, 2003
21. “Sociodemographic and clinical characteristics of patients with conversion disorder in Eastern Turkey,” Soc Psychiatr. Psychiatric Epidemiol, 38, 88-93, 2003
22. “Serum leptin levels in patients with premature ejaculation before and after citalopram treatment,” BJU Int, 91, 252-4, 2003
23. “Switching to tianeptine in patients with antidepressant-induced sexual dysfunction,” Hum Psychopharmacol Clin 18, 277-80, 2003.
24. “Neopterin production in posttraumatic stress disorder before and after pharmachotherapy,” Eur. Arch. Psychiatry Clin. Neurosci, 253, 34-6, 2003
25, “Free radicals in patients with post-traumatic stress disorder,” Eur. Arch. Psychiatry Clin. Neurosci, 253, 89-91, 2003
26. “Dissociative disorders in Turkish inpatients with conversion disorder,” Comp. Psychiatry, 44, 324-30, 2003
27. “Serum leptin and triglyceride levels in patients on antipsychotic treatment with atypical antipsychotics,” J. Clin. Psychiatry, 64, 598-604, 2003
28,“Nizatidine treatment and its relationship with leptin levels in patientts with olanzapine-induced weight gain,” Hum. Psychopharmacol. Clin. Exp, 18, 457-61, 2003
29. Atmaca, M., M. Kuloğlu, A.E. Tezcan, B. Üstündağ, “Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts”. Acta Psychiatr Scand. 108, 208-14, 2003
30.“ Weight gain, serum leptin and triglyceride levels in the patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol,” Schizophrenia Res, 60, 99-100, 2003
31. “An open clinical trial of reboxetine in the treatment of social phobia,” J. Clin. Psychopharmacol, 23, 417-9, 2003
32. “Nizatidine for the treatment of patients with quetiapine-induced weight gain”, Hum Psychopharmacol, 19:37-40 (2004)
33. “Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment,” Eur Arch Psychiatry Clin. Neurosci, 254, 231-35 (2004)
34. “A new atypical antipsychotic: quetiapine-induced sexual dysfunctions ”. Int. J. Impotance Res, 1-3 (2004)
35. “Serum leptin levels in obsessive-compulsive disorder,” Psychiatry and Clin. Neurosci, 59, 189-1 (2005)
36. “Serum folate and homocysteine levels in patients with obsessive-compulsive disorder,” Psychiatry and Clin. Neurosci, 59, 616-20 (2005)
37, “Plasma nitrate values in patients with obsessive-compulsive disorder,” Psychiatry and Clin. Neurosci, 59, 621-3 (2005)
38. “High serum leptin levels in depressive disorders with atypical features”. Psychiatry Clin Neurosci, 59:736-8 (2005)
39. “The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia. Psychiatry Clin Neurosci, 59: 652-6 (2005)
40. “Hepatitis B and Hepatitis C virus infection in institutionalized schizophrenia and other psychotic disorders patients in Eastern Turkey” Neurology Psychiatry and Brain Research 13:159-64 (2006)
41. “Neopterin levels and dexamethasone supression test in obsessive-compulsive disorder,’’ Psychiatry Res, 151: 265-70 (2007)
42. “The effects of antidepressant treatment on serum cholesterol and triglyceride levels in depressive patients” Neurology Psychiatry and Brain Research 14:13-8 (2007)
43. “Serum leptin and cholesterol values in violent and non-violent suicide attempters’’ Psychiatry Res, 158: 87-91 (2008)
44. Antioxidant enzyme and malondialdehyde levels in patient with social phobia Psychiatry Res: 95-100 (2008)
45. “A left temporal lobe arachnoid cyst in a patient with schizophrenia-likepsychosis: A case report”. Prog Neuropsychopharmacol Biol Psychiatry. 32, 1349-50 (2008)
46. “Improvement from treatment-resistant schizoaffective disorder, manic type after stopping heavy caffeine intake: A case report’’. Prog Neuropsychopharmacol Biol Psychiatry, 32, 1353-4 (2008)
47. “Arnold-Chiari I malformation association with generalized anxiety disorder: A case report’’ Prog Neuropsychopharmacol Biol Psychiatry, 32, 1613-4 (2008)
48. “A case study of Neuro-psycho-Behçet's Syndrome presenting with psychotic attack”. Clin Neurol Neurosurg 111 (10), 877-9 (2009)
49. “Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: A case report” J Psychopharmacol, 23(8), 1001-3 (2009)
50. “Obsessional symptoms associated with lamotrigine use in a patient with bipolar II disorder”. Klinik Psikofarmakoloji Bülteni /Bull Clin Psychopharmacol, 19, 414-6 (2009)
51. “Aripiprazole induced rabbit syndrome: A case report”. J Psychopharmacol, 24(3), 429-31 (2010)
52. “Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use”. J Psychopharmacol, 24, 623-24 (2010)
53. “Venlafaxine-associated nocturnal bruxism in a depressive patient succesfully treated with buspirone”. J Psychopharmacol, 24, 627-28 (2010)
54. “Phenomenology of delusions and hallucinations in patients with schizophrenia” Bull Clin Psychopharmacol, 20:204-212 (2010)
55. “Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature”. Arch Womens Ment Health. 13(5):443-447 (2010)
56. “Duloksetin Tedavisi Sırasında Gelişen Galaktore: Olgu Sunumu” Türk Psikiyatri Dergisi, 22(3):200-1 (2011)
57. “Ketiapinle Tedavi Edilen Olfaktor Referans Sendromlu Bir Olgu Sunumu” Bull Clin Psychopharmacol, 21(3):193-200 (2011)
58. “Şizofreni Alt Tiplerinde Serum IL-1β, IL-2, IL-6, IL-8 Düzeyleri” Bull Clin Psychopharmacol, 21(3):246-8 (2011)
59. “OKB ve Psikojenik Polidipsi Birlikteliği Olan Bir Borderline Erotomani Olgusu” Türkiye Klinikleri Tıp Bilimleri Dergisi, 32:271-5 (2012).
60. “Bupropion kullanımıyla oluşan görsel hallüsinasyon: Olgu Sunumu” Bull Clin Psychopharmacol, 22(2): 187-9 (2012).
61. “Olanzapine induced hair loss: a case report” Bull Clin Psychopharmacol, 22(4): 362-5 (2012).
62. “Multipl Skleroz Hastalarında Aleksitimi ile Mizaç ve Karakter Özellikleri” Nöropsikiyatri Arşivi/Archives of Neuropsychiatry 50: 34-39 (2013).
63. “Barbeksaklon Yoksunluğuna Bağlı Psikotik Bozukluk” Nöropsikiyatri Arşivi/Archives of Neuropsychiatry 50: 87-88 (2013).
64. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 45:145-9 (2013).
65. “A Case of Catatonic Schizophrenia Treated Effectively with Aripiprazole” Bull Clin Psychopharmacol, 23: 25-60 (2013).
66. Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine. Neuropsychiatr Dis Treat. 9:1545-52 (2013).
67. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia. Nord J Psychiatry. 2013.
68. Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo. Neuropsychiatr Dis Treat. 12;10:2361-7 (2014).
69. Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia. Neuropsychiatr Dis Treat. 29;11:2825-31 (2015)
70. Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome. Neuropsychiatr Dis Treat. 30;11:865-72 (2015).
71. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Archieves of Women’s Mental Health. 2015;18(5):739-40.
72. Reliability and Validity of the Turkish Version of the Clinical Opiate Withdrawal Scale (COWS). Bulletin of Clinical Psychopharmacology. 2015; 25(3):267-71.
73. Predictors of Relapse in Patients with Opioid Addiction During Buprenorphine-Naloxone Maintenance Treatment. Journal of Addiction and Neuropharmacology. 2015; 1:1.
74. Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study. Neuropsychiatr Dis Treat. 2016; 12:1261-68.
75. Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker. Acta Neuropsychiatr. 2017; 29(2):80-86.
76. The relationship between second-to-fourth digit (2D:4D) ratios and problematic and pathological Internet use among Turkish university students. J Behav Addict. 2017; 6(1):30-41.
77. Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report. Neuropsychiatr Dis Treat. 2018 Nov 9;14:3033-3035.
78. Turkish adaptation of Kessler Psychological Distress Scale: validity and reliability study. Anatolian Journal of Psychiatry 2019; 20(Suppl.1):23-31)
79. The use of naltrexone implants for the treatment of opioid addiction: a retrospective study. Anatolian Journal of Psychiatry 2019; 20(2):133-138
80. Patients without psychopathology applying for aesthetic rhinoplasty may display elevated harm avoidance and reduced self-directedness: a crosssectional, case–control study. Psychiatry and Clinical Psychopharmacology, 2019
Sertifikalar
Ödüller ve Sertifikalar
Ödüller ve Sertifikalar
Ödüller ve Sertifikalar
Ödüller ve Sertifikalar
Hastalardan Gelen Sorular
XeplionMerhaba, 26 yaşındayım. 4 aydır atipik psikoz teşhisinden do ...
AO•29.12.2021
Panik atak kalpMerhaba hocam. Benim sorunum çok mutsuz olduğum bir yıldan v ...
SB•13.10.2021
Online hasta görüşmesiMerhaba online hasta görüyormusunuz ögrenebilirmiyim teşekkü ...
GT•24.09.2021
Panik bozuklukHocam merhabalar ben panik atak ve anksiyete hastasiyim eski ...
YC•04.09.2021
Unutkanlık sorusuUnutkanlık sorusu Unutkanlik Unutkanlık Unutkanlık sorusu sa ...
MB•28.08.2021
Profil Ziyaretleri
Son 30 günlük görüntülenme
0
profil görüntülenmesi
Sık Sorulan Sorular
Prof. Dr. Murat Kuloğlu ile nasıl iletişime geçerim?
Prof. Dr. Murat Kuloğlu için online veya telefonla randevu alabilirsin.
Prof. Dr. Murat Kuloğlu için nasıl randevu alabilirim?
Prof. Dr. Murat Kuloğlu ile iletişime geçmek için profil sayfasındaki iletişim bilgilerini kullanabilirsin.
Prof. Dr. Murat Kuloğlu hangi hastanede/klinikte çalışıyor, iletişim bilgileri nedir?
Prof. Dr. Murat Kuloğlu Prof.Dr Murat Kuloğlu Özel Muayenehanesi bünyesinde çalışmaktadır. Uzmanının iletişim bilgilerine profilinden ulaşabilirsiniz
Prof. Dr. Murat Kuloğlu kimdir, hangi uzmanlık alanında hizmet veriyor?
Prof. Dr. Murat Kuloğlu, Psikiyatri uzmanıdır. Psikoz, Kişilik Bozuklukları, Travma Sonrası Stres Bozukluğu, Evlilik Problemleri, Demans ve psikiyatrik sıkıntılar, Cinsel İşlev Bozuklukları, Kumar Bağımlılığı, Sınav Kaygısı, Uyku Bozuklukları, Hastalık Kaygısı alanlarında hizmet veriyor.
Profil Ziyaretleri
Son 30 günlük görüntülenme
0
profil görüntülenmesi